Hogan Lovells

Market Access

Last month, the US Centers for Medicare and Medicaid Services released the negotiated prices for the first 10 drugs subject to the

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.